Skip to main content

The independent medical news service

08-04-2020 | Oncology | News | Article

Tocilizumab shows promise for COVID-19 treatment in people with cancer

The interleukin-6 receptor inhibitor tocilizumab warrants further investigation for the treatment of COVID-19 in patients with cancer, say the authors of a case report.

03-04-2020 | Oncology | News | Article

Early data point to predictors of severe COVID-19 in cancer patients

An analysis of cancer patients with comorbid COVID-19 in Wuhan, China, has identified factors associated with an increased risk for a more severe clinical course.

30-03-2020 | Oncology | News | Article

UK-based cancer and coronavirus registry initiated

Oncologists from the UK have jointly launched the UK Coronavirus Cancer Monitoring Project to collate data on cancer patients who acquire COVID-19.

27-03-2020 | Oncology | News | Article

COVID-19 cancer registry launched in USA

The COVID-19 and Cancer Consortium – CCC19 – which aims to collect data on cancer patients with SARS-CoV-2 infection has launched.

25-03-2020 | Oncology | News | Article

Cancer linked to increased COVID-19 risk

The risk for acquiring SARS-CoV2 infection appears to be more than twofold higher for people with cancer than the general community, indicates a chart review.

20-03-2020 | Oncology | News | Article

Early COVID-19 data raise questions on cancer patient risk

People with a current diagnosis or history of cancer may have an increased likelihood of developing COVID-19, with associated worse outcomes, suggests early research from China.

16-03-2020 | Oncology | News | Article

COVID-19 may not preclude continuation of lung cancer therapy

The continuation of anticancer therapy may be feasible in patients who acquire SARS-CoV2, say the authors of a case report of a patient with advanced adenocarcinoma and COVID-19.

11-12-2019 | Oncology | News | Article

Cancer treatment-related declines in CD4 count may increase mortality risk in people with HIV

Treatment with chemotherapy and/or radiotherapy is associated with a reduction in CD4 count in adults with HIV and cancer, relative to surgery or other therapy, and this in turn is associated with an increased risk for death, US study findings indicate.

11-11-2019 | Oncology | News | Article

‘No justification’ for HIV exclusion from ICI trials

Researchers highlight the “almost universal exclusion” of people living with HIV from clinical trials of immune checkpoint inhibitor therapies despite malignancy being the leading cause of morbidity and mortality in this population.

21-10-2019 | Oncology | News | Article

BCG vaccination linked to reduced incidence of lung cancer

Receipt of the Bacillus Calmette-Guérin vaccine may reduce the risk for developing lung cancer, suggests a secondary analysis of a clinical trial conducted in American–Indian and Alaska Native populations.

06-09-2019 | Oncology | News | Article

Influenza vaccine effective in cancer patients

The influenza vaccine has “modest” effectiveness in patients with cancer, say researchers who believe their findings support public health recommendations for vaccination in this population.

05-08-2019 | Oncology | News | Article

HIV infection associated with worse prostate cancer outcomes

Older individuals with HIV and prostate cancer have worse outcomes than corresponding cancer patients without HIV, according to a large database study from the USA.

24-07-2019 | Oncology | News | Article

HBV reactivation risk ‘moderate to high’ for EGRF–TKI-treated NSCLC

Patients with non-small-cell lung cancer undergoing treatment with an EGFR–tyrosine kinase inhibitor may have a clinically meaningful risk for reactivation of unresolved hepatitis B virus infection during treatment, study findings indicate.

03-05-2019 | Rheumatology | News | Article

Meta-analysis supports increased herpes zoster risk with JAK inhibitors

Findings from a systematic review and meta-analysis indicate that the incidence of herpes zoster among rheumatoid arthritis patients treated with Janus kinase inhibitors is higher than expected in this population, and baricitinib is associated with a significantly increased risk.

29-03-2019 | Oncology | News | Article

Flu vaccine not contraindicated for checkpoint inhibitor-treated cancer patients

A US chart review has found no increase in the incidence of severe immune-related adverse events among advanced cancer patients who receive an influenza vaccination during the 2 months before or after initiating immune checkpoint inhibitor therapy.

13-02-2019 | Oncology | News | Article

Immune checkpoint inhibitors viable in advanced cancer complicated by HIV

Immune checkpoint inhibitor therapy is well tolerated by patients with HIV infection and advanced-stage cancer and does not appear to adversely affect HIV viral load or CD4 cell count, suggest results of a systematic data review.

25-01-2019 | Oncology | News | Article

Hepatitis screening “may be warranted” following cancer diagnosis

The prevalence of hepatitis B virus and hepatitis C virus infection in patients with newly diagnosed cancer is similar to that of the US population, but a “substantial proportion” of patients are unaware of their infection, research shows.

01-11-2018 | Oncology | News | Article

Anti-PD-1 immunotherapy feasible for patients with HIV and cancer

A database analysis reported at the ESMO 2018 Congress in Munich, Germany, points to the feasibility of using immune checkpoint inhibitors in people living with HIV who develop cancer.

15-10-2018 | Oncology | Main feed | News

HPV vaccination age expanded in the USA

Click here for details

12-09-2018 | Leukaemia | News | Article

Levofloxacin reduces bacteremia during chemotherapy for childhood leukemia

Levofloxacin prophylaxis significantly reduces the risk for bacteremia among children receiving intensive chemotherapy for acute leukemia, but not among those undergoing hematopoietic stem cell transplantation, study data show.

Image Credits